ARCHIVES

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

This article is from The Cancer Letter archive.

Vol. 20 No. 33 | August 19, 1994

Download PDF Visit The Full Archive

Related Articles

Sausville to lead clinical research at Maryland.

December 5, 2003

Carter In Last Budget Asks Four Percent Increase For NCI, But Then Seeks $13.5 Million Rescission

January 23, 1981

Funding Opportunities.

April 19, 2002

Surveillance Colonoscopy Cost-Effective For High-Risk

July 30, 2010

ASTRO Names Officers; Lane Returns To Rice Univ.

January 5, 2001

Hammer’s “March Of dollars” Starts Collecting Money; Four Year Campaign Kicks Off Oct 12

September 2, 1988